In the clinical study Neurim V, patients were treated with Circadin® up to 12 months12. In the clinical study NEU 951003, patients were randomized to Circadin® or placebo for 6 months, and then continued Circadin® for up to 12 months20. For some patients, the total duration of treatment was therefore 18 months.
In a study of long term treatment with Circadin® in which the treatment duration ranged from 6-72 months in 88 children (aged 5-15) with neurodevelopmental disorders Circadin’s® efficacy and good safety profile was confirmed58.
Posted in: Other topics
